DXCM logo DexCom +
DexCom
+

DexCom (DXCM) Business News

Track DexCom in real time with a live news feed covering DexCom stock news, official press releases, company announcements, and an archive of historical DexCom news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

American Capital Management Inc. Purchases Shares of 235,152 DexCom, Inc. $DXCM

Defense World

3:39 AM | Thursday | Aug 27, 2026

news photo
Loading...

American Capital Management Inc. bought a new stake in DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 235,152 shares of the medical device company's stock, valued at approximately $15,837,000. American Capital Management Inc.

Read full article redirect
3:39 AM | Thursday | Aug 27, 2026

American Capital Management Inc. Purchases Shares of 235,152 DexCom, Inc. $DXCM

Defense World

American Capital Management Inc. bought a new stake in DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 235,152 shares of the medical device company's stock, valued at approximately $15,837,000. American Capital Management Inc.

Read full article arrow
News Thumbnail
3:39 AM | Thursday | Aug 27, 2026

American Capital Management Inc. Purchases Shares of 235,152 DexCom, Inc. $DXCM

Defense World

American Capital Management Inc. bought a new stake in DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 235,152 shares of the medical device company's stock, valued at approximately $15,837,000. American Capital Management Inc.

Read full article arrow
News Thumbnail
11:26 AM | Tuesday | Aug 25, 2026

Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now?

Zacks Investment Research

ABT edges DXCM on price-target upside and valuation, while both pursue CGM growth through innovation, adoption and strong liquidity.

Read full article arrow
News Thumbnail
3:56 AM | Monday | Aug 24, 2026

Great Lakes Advisors LLC Invests $369,000 in DexCom, Inc. $DXCM

Defense World

Great Lakes Advisors LLC purchased a new position in shares of DexCom, Inc. (NASDAQ: DXCM) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,472 shares of the medical device company's stock, valued at approximately $369,000. Other hedge funds also recently added to

Read full article arrow
News Thumbnail
10:51 AM | Friday | Aug 21, 2026

Here's Why DexCom (DXCM) is a Strong Momentum Stock

Zacks Investment Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read full article arrow
News Thumbnail
3:18 AM | Thursday | Aug 20, 2026

Aurora Investment Counsel Invests $2.34 Million in DexCom, Inc. $DXCM

Defense World

Aurora Investment Counsel bought a new stake in DexCom, Inc. (NASDAQ: DXCM) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 34,744 shares of the medical device company's stock, valued at approximately $2,340,000. DexCom comprises 1.2% of Aurora Investment Counsel's investment portfolio, making

Read full article arrow
News Thumbnail
10:46 AM | Thursday | Aug 13, 2026

Here's Why DexCom (DXCM) is a Strong Growth Stock

Zacks Investment Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read full article arrow
News Thumbnail
3:41 PM | Wednesday | Aug 12, 2026

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

Zacks Investment Research

DexCom's broader CGM coverage, G7 15 Day rollout and rising margins support growth, but premium valuation, competition and litigation temper upside.

Read full article arrow
News Thumbnail
3:36 PM | Wednesday | Aug 12, 2026

Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?

Zacks Investment Research

DexCom raises its 2026 revenue and margin outlook as G7 15 Day efficiencies lift profitability, while FX and transition costs remain key tests.

Read full article arrow
News Thumbnail
3:36 PM | Wednesday | Aug 12, 2026

DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?

Zacks Investment Research

DexCom's 52.5% three-month rally is backed by earnings growth and margin gains, but premium valuation, competition and litigation raise the bar.

Read full article arrow
News Thumbnail
3:36 PM | Wednesday | Aug 12, 2026

DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?

Zacks Investment Research

DXCM's 2026 rebound is backed by stronger growth, G7 15 Day adoption and broader CGM access, but competition and reimbursement remain key risks.

Read full article arrow
News Thumbnail